Norway Oligonucleotide Synthesis Market Size & Outlook

Name: Norway Oligonucleotide Synthesis Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The oligonucleotide synthesis market in Norway is expected to reach a projected revenue of US$ 67.3 million by 2033. A compound annual growth rate of 9.4% is expected of Norway oligonucleotide synthesis market from 2026 to 2033.

Norway oligonucleotide synthesis product outlook (Revenue, USD million, 2021-2033)
- Oligonucleotides
  - DNA
    - Column-based
    - Array-based
  - RNA
    - Short RNA Oligos (<65 nt)
    - Long RNA Oligos (>65 nt)
    - CRISPR (sgRNA)
- Equipment/Synthesizer
- Reagents
- Services
  - DNA
    - Custom Oligo Synthesis Services
      - 25 nmol
      - 50 nmol
      - 200 nmol
      - 1000 nmol
      - 10000 nmol
    - Modification Services
    - Purification Services
  - RNA
    - Custom Oligo Synthesis Services
      - 25 nmol
      - 100 nmol
      - 1000 nmol
      - 10000 nmol
    - Modification Services
    - Purification Services
Norway oligonucleotide synthesis application outlook (Revenue, USD million, 2021-2033)
- PCR Primers
- PCR Assays and Panels
- Sequencing
- DNA Microarrays
- Fluorescence In Situ Hybridization (FISH)
- Antisense Oligonucleotides
- Other Applications
Norway oligonucleotide synthesis end use outlook (Revenue, USD million, 2021-2033)
- Academic Research Institutes
- Diagnostic Laboratories
- Pharmaceutical - Biotechnology Companies

Norway Oligonucleotide Synthesis Market Size & Outlook

Sign up - it's easy, and free!